Changes in co-morbidity pattern in patients starting renal replacement therapy in Europe—data from the ERA-EDTA Registry
Author(s) -
María Laura Ceretta,
Marlies Noordzij,
Rosario Luxardo,
Johan De Meester,
José María Abad Díez,
Patrik Finne,
James Heaf,
Cécile Couchoud,
Reinhard Kramar,
Frédéric Collart,
Aleix Cases,
Runólfur Pálsson,
Anna Varberg Reisæter,
Helena Rydell,
Ziad A. Massy,
Kitty J. Jager,
Anneke Kramer
Publication year - 2017
Publication title -
nephrology dialysis transplantation
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.654
H-Index - 168
eISSN - 1460-2385
pISSN - 0931-0509
DOI - 10.1093/ndt/gfx355
Subject(s) - medicine , renal replacement therapy , malignancy , diabetes mellitus , peritoneal dialysis , kidney disease , dialysis , comorbidity , hemodialysis , disease , heart failure , pediatrics , intensive care medicine , endocrinology
Patients starting renal replacement therapy (RRT) for end-stage renal disease often present with one or more co-morbidities. This study explored the prevalence of co-morbidities in patients who started RRT in Europe during the period from 2005 to 2014.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom